Clinical Trial

Northwestern Neuromuscular Disease Biorepository

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this research is to collect clinical data and tissue samples from adult patients with neuromuscular disease cared for at the Northwestern Memorial Hospital neuromuscular clinic (Lavin Building, 19th floor). This study has the following aims: Aim 1: To consent a large cohort of adult study participants with neuromuscular disorders, including but not limited to motor neuron diseases, neuropathies, neuromuscular junction disorders, and myopathies for participation in the biorepository and to collect longitudinal data on their clinical disease phenotypes. Aim 2: To obtain and store biological samples from biorepository study participants, including whole blood, plasma, serum, peripheral blood mononuclear cells \[PBMCs\], skin biopsies, and cerebrospinal fluid. Aim 3: To develop a data-sharing process to provide de-identified biorepository participant clinical data and samples to partnered investigators to expedite discovery in neuromuscular disease diagnosis and treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07477509
Lead Sponsor Northwestern University
Conditions Neuromuscular Diseases (NMD)
Enrollment 2,500 participants
Start Date 2026-05-01
Primary Completion 2050-03 (estimated)
Study Completion 2050-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-26